Akorn (AKRX) - 12 Year Stock Split History

Historical stock splits for Akorn since 2006. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.011B $0.841B
Akorn, Inc. is a specialty generic pharmaceutical company engaged in the development, manufacture and marketing of multisource and branded pharmaceuticals. They specialize in difficult-to-manufacture sterile and non-sterile dosage forms including: ophthalmics, injectables, oral liquids, otics, topicals, inhalants, and nasal sprays. Akorn markets its products to retail pharmacies, ophthalmologists, optometrists, physicians, veterinarians, hospitals, clinics, wholesalers, distributors, group purchasing organizations, and government agencies. Their strategy is focused on continuing to strengthen our leadership position in the development and marketing of specialized generic and branded pharmaceuticals, over-the-counter (`OTC`) drug products and animal health products.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $58.790B 10.34
Teva Pharmaceutical Industries (TEVA) Israel $23.449B 6.13
Mylan (MYL) United Kingdom $18.371B 7.76
Dr Reddy's Laboratories (RDY) India $4.850B 28.96
Supernus Pharmaceuticals (SUPN) United States $2.810B 35.23
AxoGen (AXGN) United States $1.908B 0.00
Mallinckrodt Public Limited Company (MNK) United Kingdom $1.820B 3.07
Assembly Biosciences (ASMB) United States $0.846B 0.00
Homology Medicines (FIXX) United States $0.802B 0.00
Amphastar Pharmaceuticals (AMPH) United States $0.776B 72.35
CymaBay Therapeutics (CBAY) United States $0.752B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.732B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.619B 0.00
Voyager Therapeutics (VYGR) United States $0.593B 0.00
Corium (CORI) United States $0.288B 0.00
Teligent (TLGT) United States $0.215B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.141B 0.00
Sol-Gel Technologies (SLGL) Israel $0.130B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.075B 0.00
Versartis (VSAR) United States $0.072B 0.00
Aevi Genomic Medicine (GNMX) United States $0.054B 0.00
Evoke Pharma (EVOK) United States $0.045B 0.00
Pernix Therapeutics Holdings (PTX) United States $0.029B 0.00
Acasti Pharma (ACST) Canada $0.020B 0.00
Agile Therapeutics (AGRX) United States $0.017B 0.00
China Pharma Holdings (CPHI) China $0.011B 0.00